Center for Scientific Review; Notice of Closed Meetings, 4581-4582 [2015-01486]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Targeting
Temporal Dynamics of the Brain Activity for
the Treatment of Cognitive Deficits.
Date: February 17–18, 2015.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181
MSC 7846, Bethesda, MD 20892–7846, 301–
435–1236, zhaow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Academic
Research Enhancement Award.
Date: February 25, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Lee Rosen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5116,
MSC 7854, Bethesda, MD 20892, (301) 435–
1171, rosenl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery for Aging,
Neuropsychiatric and Neurologic Disorders.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: J W Marriott New Orleans, 614
Canal Street, New Orleans, LA 70130.
Contact Person: Yuan Luo, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5207, MSC 7846, Bethesda, MD
20892, 301–915–6303, luoy2@mail.nih.gov.
VerDate Sep<11>2014
16:41 Jan 27, 2015
Jkt 235001
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Sensory and Motor
Neurosciences, Cognition and Perception.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: JW Marriott Hotel, 614 Canal St,
New Orleans, LA 70130.
Contact Person: Sharon S Low, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 7846, Bethesda, MD 20892, 301–237–
1487, lowss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Aging and Development, Auditory,
Vision and Low Vision Technologies.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites DC Convention
Center, Embassy Hotel, 900 10th street,
Washington, DC 20001.
Contact Person: Paek-Gyu Lee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892, (301) 613–
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Medical Imaging.
Date: February 26–27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Los Angeles Marriott at LAX, 5855
West Century Blvd., Los Angeles, CA 90245.
Contact Person: Leonid V Tsap, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7854, Bethesda, MD 20892, (301) 435–
2507, tsapl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Immunology.
Date: February 26–27, 2015.
Time: 8:30 a.m. to 5:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Patrick K Lai, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2215,
MSC 7812, Bethesda, MD 20892, 301–435–
1052, laip@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Basic and Integrative
Bioengineering.
Date: February 26, 2015.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Paul Sammak, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
4581
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
MSC 7892, Bethesda, MD 20892, 301–435–
0601, sammakpj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Bioengineering Sciences.
Date: February 26–27, 2015.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ping Fan, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5154,
MSC 7840, Bethesda, MD 20892, 301–408–
9971, fanp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PARs:
Developmental Pharmacology and
Toxicology.
Date: February 26, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Bonnie L Burgess-Beusse,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, 301–435–
1783, beusseb@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel.
Date: February 26, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: David R Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892, 301–435–
2902, filpuladr@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Musculoskeletal Rehabilitation.
Date: February 26, 2015.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Admiral Fell Inn, 888 South
Broadway, Baltimore, MD 21231.
Contact Person: Rajiv Kumar, Ph.D., IRG
Chief, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 4216, MSC 7802, Bethesda, MD 20892,
301–435–1212, kumarra@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846-93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\28JAN1.SGM
28JAN1
4582
Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices
Dated: January 22, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–01486 Filed 1–27–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2014–0720]
Request for Public Comment on
Waiver Revisions for Certain
Medications and Suggestions for Risk
Evaluation
Coast Guard, DHS.
Notice of proposed policy
clarification and request for comments.
AGENCY:
ACTION:
The Coast Guard is seeking
public comment on the policy
clarification proposed in this Notice
regarding the criteria for granting
medical waivers to mariners who
require the use of potentially impairing
prescription medications. The Coast
Guard is also seeking input regarding
effective methods of risk evaluation of
such mariners. Current Coast Guard
guidance states that the ‘‘use of certain
medications is considered disqualifying
for the issuance of credentials,’’ and that
‘‘the underlying cause or need for use of
these medications and potential side
effects may result in denial of a
credential application or require a
waiver.’’ Current guidance specifically
identifies that use of benzodiazepine
medications, opioid and opiate
medications, non-benzodiazepine
sedative hypnotic medications, and
barbiturate medications require a
waiver, but does not specify the factors
that the Coast Guard will consider in
making its determination on whether
the risks associated with use of these
medications are low enough to warrant
consideration for a waiver.
The Coast Guard is proposing
additions to the current medication
policy that will clarify the
circumstances that the Coast Guard will
consider when determining whether to
grant a medical waiver for use of these
medications. Additionally, the Coast
Guard is proposing to include a safety
warning to mariners advising them to
refrain from use of impairing
medications while operating under the
authority of their credential. The Coast
Guard is seeking comments from the
public on whether the proposed policy
adequately addresses safety concerns
regarding merchant mariners whose
medical conditions require the use of
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:41 Jan 27, 2015
Jkt 235001
medications that have the potential to
impair cognitive ability, judgment or
reaction time.
DATES: Comments and related material
must either be submitted to our online
docket via https://www.regulations.gov
on or before March 30, 2015 or reach the
Docket Management Facility by that
date.
ADDRESSES: You may submit comments
identified by docket number USCG–
2014–0720 using any one of the
following methods:
(1) Federal eRulemaking Portal:
https://www.regulations.gov.
(2) Fax: 202–493–2251.
(3) Mail: Docket Management Facility
(M–30), U.S. Department of
Transportation, West Building Ground
Floor, Room W12–140, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001.
(4) Hand delivery: Same as mail
address above, between 9 a.m. and 5
p.m., Monday through Friday, except
Federal holidays. The telephone number
is 202–366–9329.
To avoid duplication, please use only
one of these four methods. See the
‘‘Public Participation and Request for
Comments’’ portion of the
SUPPLEMENTARY INFORMATION section
below for instructions on submitting
comments.
FOR FURTHER INFORMATION CONTACT: If
you have questions about this notice,
call or email Lieutenant Ashley Holm,
Mariner Credentialing Program Policy
Division (CG–CVC–4), U.S. Coast Guard,
telephone 202–372–2357, email
MMCPolicy@uscg.mil. If you have
questions on viewing material in the
docket, call Docket Operations at 202–
366–9826.
SUPPLEMENTARY INFORMATION:
Public Participation
You may submit comments and
related material regarding whether the
policy clarifications proposed in this
Notice should be incorporated into a
final policy on issuing medical waivers
to mariners whose medical conditions
require use of benzodiazepine
medications, opioid and opiate
medications, non-benzodiazepine
sedative hypnotic medications, or
barbiturate medications. All comments
received will be posted, without change,
to https://www.regulations.gov and will
include any personal information you
have provided.
Submitting Comments
If you submit a comment, please
include the docket number for this
notice (USCG–2014–0720) and provide
a reason for each suggestion or
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
recommendation. You may submit your
comments and material online or by fax,
mail or hand delivery, but please use
only one of these means. We
recommend that you include your name
and a mailing address, an email address,
or a telephone number in the body of
your document so that we can contact
you if we have questions regarding your
submission.
To submit your comment online, go to
https://www.regulations.gov, type the
docket number (USCG–2014–0720) in
the ‘‘SEARCH’’ box and click
‘‘SEARCH.’’ Click on ‘‘Submit a
Comment’’ on the line associated with
this notice.
If you submit your comments by mail
or hand delivery, submit them in an
unbound format, no larger than 81⁄2 by
11 inches, suitable for copying and
electronic filing. If you submit them by
mail and would like to know that they
reached the Facility, please enclose a
stamped, self-addressed postcard or
envelope. We will consider all
comments and material received during
the comment period.
Viewing the comments: To view
comments, go to https://
www.regulations.gov, type the docket
number (USCG–2014–0720) in the
‘‘SEARCH’’ box and click ‘‘SEARCH.’’
Click on ‘‘Open Docket Folder’’ on the
line associated with this rulemaking.
You may also visit the Docket
Management Facility in Room W12–140
on the ground floor of the Department
of Transportation West Building, 1200
New Jersey Avenue SE., Washington,
DC 20590, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal
holidays. We have an agreement with
the Department of Transportation to use
their Docket Management Facility.
Privacy Act: Anyone can search the
electronic form of comments received
into any of our dockets by the name of
the individual submitting the comment
(or signing the comment, if submitted
on behalf of an association, business,
labor union, etc.). You may review a
Privacy Act system of records notice
regarding our public dockets in the
January 17, 2008, issue of the Federal
Register (73 FR 3316).
Background and Purpose
Coast Guard regulations in 46 CFR
10.302 contain the medical standards
that merchant mariners must meet prior
to being issued a merchant mariner
credential (MMC). In cases where the
mariner does not meet the medical
standards in 46 CFR 10.302, waivers
may be granted when extenuating
circumstances exist that warrant special
consideration. 46 CFR 10.303.
Additionally, 46 CFR 10.304 specifies
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 80, Number 18 (Wednesday, January 28, 2015)]
[Notices]
[Pages 4581-4582]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01486]
[[Page 4581]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Targeting Temporal Dynamics of the Brain Activity for the
Treatment of Cognitive Deficits.
Date: February 17-18, 2015.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Wei-Qin Zhao, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5181 MSC 7846, Bethesda, MD 20892-7846, 301-
435-1236, zhaow@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Academic Research Enhancement Award.
Date: February 25, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Lee Rosen, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5116, MSC 7854, Bethesda, MD 20892, (301) 435-
1171, rosenl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery for Aging, Neuropsychiatric
and Neurologic Disorders.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: J W Marriott New Orleans, 614 Canal Street, New Orleans,
LA 70130.
Contact Person: Yuan Luo, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD 20892, 301-915-
6303, luoy2@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Sensory and Motor Neurosciences, Cognition and
Perception.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: JW Marriott Hotel, 614 Canal St, New Orleans, LA 70130.
Contact Person: Sharon S Low, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5104, MSC 7846, Bethesda, MD 20892, 301-237-
1487, lowss@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Aging and Development, Auditory, Vision and
Low Vision Technologies.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites DC Convention Center, Embassy Hotel, 900
10th street, Washington, DC 20001.
Contact Person: Paek-Gyu Lee, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4201, MSC 7812, Bethesda, MD 20892, (301) 613-
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Medical Imaging.
Date: February 26-27, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Los Angeles Marriott at LAX, 5855 West Century Blvd., Los
Angeles, CA 90245.
Contact Person: Leonid V Tsap, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5128, MSC 7854, Bethesda, MD 20892, (301) 435-
2507, tsapl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowship: Immunology.
Date: February 26-27, 2015.
Time: 8:30 a.m. to 5:00 a.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Patrick K Lai, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2215, MSC 7812, Bethesda, MD 20892, 301-435-
1052, laip@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Basic and Integrative Bioengineering.
Date: February 26, 2015.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Paul Sammak, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6185, MSC 7892, Bethesda, MD 20892, 301-435-
0601, sammakpj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Bioengineering Sciences.
Date: February 26-27, 2015.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ping Fan, MD, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5154, MSC 7840, Bethesda, MD 20892, 301-408-
9971, fanp@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PARs: Developmental Pharmacology and Toxicology.
Date: February 26, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Bonnie L Burgess-Beusse, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD
20892, 301-435-1783, beusseb@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel.
Date: February 26, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: David R Filpula, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD
20892, 301-435-2902, filpuladr@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Musculoskeletal Rehabilitation.
Date: February 26, 2015.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Admiral Fell Inn, 888 South Broadway, Baltimore, MD
21231.
Contact Person: Rajiv Kumar, Ph.D., IRG Chief, Center for
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301-435-1212,
kumarra@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 4582]]
Dated: January 22, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-01486 Filed 1-27-15; 8:45 am]
BILLING CODE 4140-01-P
